Christopher Moertel, MD
Professor, Department of Pediatrics

Contact Info
Professor, Department of Pediatrics
Faculty Member, Division of Pediatric Hematology and Oncology
Medical Director, Pediatric Neuro-Oncology and Neurofibromatosis Programs
Co-Medical Director, Journey Clinic
Clinical Neuro-Oncology Leader, Brain Tumor Program
Pediatric Neuro-Oncologist
MD, University of Minnesota Medical School, Minneapolis, MN
Residency in Pediatrics, Baylor College of Medicine, Houston, TX
Fellowship in Pediatric Hematology/Oncology, Mayo Clinic/Mayo Graduate School of Medicine, Rochester, MN
Summary
Dr. Moertel graduated from the University of Minnesota Medical School. He completed his internship and residency in Pediatrics at the Baylor College of Medicine in Houston, Texas. He then completed his fellowship in Pediatric Hematology and Oncology at the Mayo Clinic/ Mayo Graduate School of Medicine in Rochester, Minnesota. He joined the medical staff at Children’s Hospitals and Clinics of Minnesota in 1990. He is currently the Medical director of the Journey Clinic. While at Children’s, he served as Chief of Staff, Medical Director of Hematology/Oncology, and Lead Physician in the Theodora Lang Oncology Clinic, among other leadership positions. While at Children’s, he was co-director of neuro-oncology, founder and medical director of the Neurocutaneous Syndromes Clinic Without Walls, and attending physician in the Fairview/University Hemophilia and Thrombosis Center. Dr. Moertel has served on numerous national and local professional committees and is the author of a number of book chapters, articles, and abstracts. Special interests include rare pediatric tumors, neurofibromatosis-associated neoplasia, and the therapy of children with brain and spinal cord tumors.
Awards & Recognition
Research
Publications
- Keng VW, Rahrmann EP, Watson AL, Tschida BR, Moertel CL, Jessen WJ, Rizvi TA, Collins MH, Ratner N, Largaespada DA. PTEN and NF1 Inactivation in Schwann Cells Produces a Severe Phenotype in the Peripheral Nervous System That Promotes the Development and Malignant Progression of Peripheral Nerve Sheath Tumors. Cancer Res. 2012 Jul 1;72(13):3405-13. Epub 2012 Jun 14. PMID: 22700876 [PubMed - in process]
- Priest JR, Hill DA, Williams GM, Moertel CL, Messinger Y, Finkelstein MJ, Dehner LP; International Pleuropulmonary Blastoma Registry. Type I pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry. J Clin Oncol. 2006 Sep 20;24(27):4492-8. PMID: 16983119 [PubMed - indexed for MEDLINE]
- Perko R, Messinger Y, Moertel C. Pseudometastasis secondary to histoplasmosis infection: false-positive PET/CT findings. Pediatr Blood Cancer. 2010 Apr;54(4):621-3. PMID: 19998468 [PubMed - indexed for MEDLINE]
- Yi JS, Moertel CL, Baker KS. Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation. J Pediatr. 2009 May;154(5):766-8. PMID: 19364562 [PubMed - indexed for MEDLINE]
Clinical
Specialties
- Pediatric Cancer
- Pediatric Hematology/Oncology
- Pediatrics
Clinics
Journey Clinic - Center for Children with Cancer and Blood Disorders;Journey Clinic - Center for Pediatric Blood and Marrow Transplantation;Pediatric Specialty Care-Explorer Clinic;Specialty Infusion and Procedure Center
Board Certifications
- American Board of Pediatrics - Pediatric Hematology/Oncology
Clinical Interests
Pediatric neuro-oncology; Rare pediatric tumors; Neurofibromatosis-associated neoplasia; Therapy of children with brain and spinal cord tumors
Hospital Privileges
M Health Fairview Masonic Children's Hospital; University of Minnesota Medical Center